United States Biotechnology & Medical Research

Urovant Sciences Ltd (UROV)

Track

Track

Ticker: UROV Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Roivant Sciences Ltd. Large shareholder
Transaction date
Sale
Price
0.00
Quantity 22,860,013
Value US$0
Katkin Keith PEO;CEO/Urovant Sciences, Inc. Executive Director
Transaction date
Planned sale
Price
12.78
Quantity 120,000 -100.0%
Value US$1,533,600
QVT Associates GP LLC Large shareholder
Transaction date
Planned purchase
Price
8.17
Quantity 4,957 +0.0%
Value US$40,495
1.5
Machado Patrick Large shareholder
Transaction date
Planned purchase
Price
8.17
Quantity 4,957 +0.0%
Value US$40,495
2.4
Lo Andrew Large shareholder
Transaction date
Planned purchase
Price
8.17
Quantity 4,957 +0.0%
Value US$40,495
Dexxon Holdings Ltd. Large shareholder
Transaction date
Planned purchase
Price
8.17
Quantity 4,957 +0.0%
Value US$40,495
3.2
SVF Investments (UK) Ltd Large shareholder
Transaction date
Planned purchase
Price
8.17
Quantity 4,957 +0.0%
Value US$40,495
1.9
Roivant Sciences Ltd. Large shareholder
Transaction date
Planned purchase
Price
8.17
Quantity 4,957 +0.0%
Value US$40,495
QVT Associates GP LLC Large shareholder
Transaction date
Planned purchase
Price
8.21
Quantity 6,706 +0.0%
Value US$55,061
1.5
Machado Patrick Large shareholder
Transaction date
Planned purchase
Price
8.21
Quantity 6,706 +0.0%
Value US$55,061
2.4
Lo Andrew Large shareholder
Transaction date
Planned purchase
Price
8.21
Quantity 6,706 +0.0%
Value US$55,061
Dexxon Holdings Ltd. Large shareholder
Transaction date
Planned purchase
Price
8.21
Quantity 6,706 +0.0%
Value US$55,061
3.2
SVF Investments (UK) Ltd Large shareholder
Transaction date
Planned purchase
Price
8.21
Quantity 6,706 +0.0%
Value US$55,061
1.9
Roivant Sciences Ltd. Large shareholder
Transaction date
Planned purchase
Price
8.21
Quantity 6,706 +0.0%
Value US$55,061
QVT Associates GP LLC Large shareholder
Transaction date
Planned purchase
Price
8.53
Quantity 6,541 +0.0%
Value US$55,825
1.5
Machado Patrick Large shareholder
Transaction date
Planned purchase
Price
8.53
Quantity 6,541 +0.0%
Value US$55,825
2.4
Lo Andrew Large shareholder
Transaction date
Planned purchase
Price
8.53
Quantity 6,541 +0.0%
Value US$55,825
Dexxon Holdings Ltd. Large shareholder
Transaction date
Planned purchase
Price
8.53
Quantity 6,541 +0.0%
Value US$55,825
3.2
SVF Investments (UK) Ltd Large shareholder
Transaction date
Planned purchase
Price
8.53
Quantity 6,541 +0.0%
Value US$55,825
1.9
Roivant Sciences Ltd. Large shareholder
Transaction date
Planned purchase
Price
8.53
Quantity 6,541 +0.0%
Value US$55,825
1.9
Roivant Sciences Ltd. Large shareholder
Transaction date
Planned purchase
Price
7.91
Quantity 7,144 +0.0%
Value US$56,514
Dexxon Holdings Ltd. Large shareholder
Transaction date
Planned purchase
Price
7.91
Quantity 7,144 +0.0%
Value US$56,514
3.2
SVF Investments (UK) Ltd Large shareholder
Transaction date
Planned purchase
Price
7.91
Quantity 7,144 +0.0%
Value US$56,514
2.4
Lo Andrew Large shareholder
Transaction date
Planned purchase
Price
7.91
Quantity 7,144 +0.0%
Value US$56,514
QVT Associates GP LLC Large shareholder
Transaction date
Planned purchase
Price
7.91
Quantity 7,144 +0.0%
Value US$56,514
1.5
Machado Patrick Large shareholder
Transaction date
Planned purchase
Price
7.91
Quantity 7,144 +0.0%
Value US$56,514
1.9
Roivant Sciences Ltd. Large shareholder
Transaction date
Planned purchase
Price
7.95
Quantity 7,367 +0.0%
Value US$58,543
Dexxon Holdings Ltd. Large shareholder
Transaction date
Planned purchase
Price
7.95
Quantity 7,367 +0.0%
Value US$58,543
3.2
SVF Investments (UK) Ltd Large shareholder
Transaction date
Planned purchase
Price
7.95
Quantity 7,367 +0.0%
Value US$58,543
2.4
Lo Andrew Large shareholder
Transaction date
Planned purchase
Price
7.95
Quantity 7,367 +0.0%
Value US$58,543
QVT Associates GP LLC Large shareholder
Transaction date
Planned purchase
Price
7.95
Quantity 7,367 +0.0%
Value US$58,543
1.5
Machado Patrick Large shareholder
Transaction date
Planned purchase
Price
7.95
Quantity 7,367 +0.0%
Value US$58,543
1.9
Roivant Sciences Ltd. Large shareholder
Transaction date
Planned purchase
Price
8.30
Quantity 7,500 +0.0%
Value US$62,244
Dexxon Holdings Ltd. Large shareholder
Transaction date
Planned purchase
Price
8.30
Quantity 7,500 +0.0%
Value US$62,244
3.2
SVF Investments (UK) Ltd Large shareholder
Transaction date
Planned purchase
Price
8.30
Quantity 7,500 +0.0%
Value US$62,244
2.4
Lo Andrew Large shareholder
Transaction date
Planned purchase
Price
8.30
Quantity 7,500 +0.0%
Value US$62,244
QVT Associates GP LLC Large shareholder
Transaction date
Planned purchase
Price
8.30
Quantity 7,500 +0.0%
Value US$62,244
1.5
Machado Patrick Large shareholder
Transaction date
Planned purchase
Price
8.30
Quantity 7,500 +0.0%
Value US$62,244
1.9
Roivant Sciences Ltd. Large shareholder
Transaction date
Planned purchase
Price
8.58
Quantity 7,189 +0.0%
Value US$61,694
QVT Associates GP LLC Large shareholder
Transaction date
Planned purchase
Price
8.58
Quantity 7,189 +0.0%
Value US$61,694
1.5
Machado Patrick Large shareholder
Transaction date
Planned purchase
Price
8.58
Quantity 7,189 +0.0%
Value US$61,694
3.2
SVF Investments (UK) Ltd Large shareholder
Transaction date
Planned purchase
Price
8.58
Quantity 7,189 +0.0%
Value US$61,694
2.4
Lo Andrew Large shareholder
Transaction date
Planned purchase
Price
8.58
Quantity 7,189 +0.0%
Value US$61,694
Dexxon Holdings Ltd. Large shareholder
Transaction date
Planned purchase
Price
8.58
Quantity 7,189 +0.0%
Value US$61,694
1.9
Roivant Sciences Ltd. Large shareholder
Transaction date
Planned purchase
Price
8.35
Quantity 7,500 +0.0%
Value US$62,594
QVT Associates GP LLC Large shareholder
Transaction date
Planned purchase
Price
8.35
Quantity 7,500 +0.0%
Value US$62,594
1.5
Machado Patrick Large shareholder
Transaction date
Planned purchase
Price
8.35
Quantity 7,500 +0.0%
Value US$62,594
3.2
SVF Investments (UK) Ltd Large shareholder
Transaction date
Planned purchase
Price
8.35
Quantity 7,500 +0.0%
Value US$62,594
2.4
Lo Andrew Large shareholder
Transaction date
Planned purchase
Price
8.35
Quantity 7,500 +0.0%
Value US$62,594
Dexxon Holdings Ltd. Large shareholder
Transaction date
Planned purchase
Price
8.35
Quantity 7,500 +0.0%
Value US$62,594
1.9
Roivant Sciences Ltd. Large shareholder
Transaction date
Planned purchase
Price
7.97
Quantity 6,649 +0.0%
Value US$52,959
QVT Associates GP LLC Large shareholder
Transaction date
Planned purchase
Price
7.97
Quantity 6,649 +0.0%
Value US$52,959
1.5
Machado Patrick Large shareholder
Transaction date
Planned purchase
Price
7.97
Quantity 6,649 +0.0%
Value US$52,959
3.2
SVF Investments (UK) Ltd Large shareholder
Transaction date
Planned purchase
Price
7.97
Quantity 6,649 +0.0%
Value US$52,959
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2020-02-21 2020-02-19 B Purchase
Sumitomo Chemical Co., Ltd.
54,091 -43.9%
29.81
US$2,191,331 		54,091 -43.9% 29.81 US$2,191,331
2020-02-21 2020-02-19 B Purchase
Sumitomo Chemical Co., Ltd.
24,041 -44.0%
328.86
US$282,566 		24,041 -44.0% 328.86 US$282,566
2020-02-21 2020-02-19 B Purchase
Sumitomo Chemical Co., Ltd.
52,087 -49.9%
89.96
US$4,634,471 		52,087 -49.9% 89.96 US$4,634,471
2019-12-31 2019-12-27 S Sale Roivant Sciences Ltd. Large shareholder
22,860,013
0.00
US$0 		22,860,013 0.00 US$0
2019-12-11 2019-12-09 PlS Planned sale Katkin Keith

PEO;CEO/Urovant Sciences, Inc.

Executive Director
120,000 -100.0%
12.78
US$1,533,600 		120,000 -100.0% 12.78 US$1,533,600
2019-06-19 2019-06-19 PP Planned purchase
QVT Associates GP LLC
Large shareholder
4,957 +0.0%
8.17
US$40,495 		4,957 +0.0% 8.17 US$40,495
2019-06-19 2019-06-19 PP Planned purchase
2.0
VIKING GLOBAL PERFORMANCE LLC
Large shareholder
4,957 +0.0%
8.17
US$40,495 		4,957 +0.0% 8.17 US$40,495
2019-06-19 2019-06-19 PP Planned purchase
1.5
Machado Patrick
Large shareholder
4,957 +0.0%
8.17
US$40,495 		4,957 +0.0% 8.17 US$40,495
2019-06-19 2019-06-19 PP Planned purchase
3.2
VIKING GLOBAL INVESTORS LP
Large shareholder
4,957 +0.0%
8.17
US$40,495 		4,957 +0.0% 8.17 US$40,495
2019-06-19 2019-06-19 PP Planned purchase
2.4
Lo Andrew
Large shareholder
4,957 +0.0%
8.17
US$40,495 		4,957 +0.0% 8.17 US$40,495
2019-06-19 2019-06-19 PP Planned purchase
Dexxon Holdings Ltd.
Large shareholder
4,957 +0.0%
8.17
US$40,495 		4,957 +0.0% 8.17 US$40,495
2019-06-19 2019-06-19 PP Planned purchase
3.2
SVF Investments (UK) Ltd
Large shareholder
4,957 +0.0%
8.17
US$40,495 		4,957 +0.0% 8.17 US$40,495
2019-06-19 2019-06-19 PP Planned purchase
1.9
Roivant Sciences Ltd.
Large shareholder
4,957 +0.0%
8.17
US$40,495 		4,957 +0.0% 8.17 US$40,495
2019-06-19 2019-06-18 PP Planned purchase
QVT Associates GP LLC
Large shareholder
6,706 +0.0%
8.21
US$55,061 		6,706 +0.0% 8.21 US$55,061
2019-06-19 2019-06-18 PP Planned purchase
2.0
VIKING GLOBAL PERFORMANCE LLC
Large shareholder
6,706 +0.0%
8.21
US$55,061 		6,706 +0.0% 8.21 US$55,061
2019-06-19 2019-06-18 PP Planned purchase
1.5
Machado Patrick
Large shareholder
6,706 +0.0%
8.21
US$55,061 		6,706 +0.0% 8.21 US$55,061
2019-06-19 2019-06-18 PP Planned purchase
3.2
VIKING GLOBAL INVESTORS LP
Large shareholder
6,706 +0.0%
8.21
US$55,061 		6,706 +0.0% 8.21 US$55,061
2019-06-19 2019-06-18 PP Planned purchase
2.4
Lo Andrew
Large shareholder
6,706 +0.0%
8.21
US$55,061 		6,706 +0.0% 8.21 US$55,061
2019-06-19 2019-06-18 PP Planned purchase
Dexxon Holdings Ltd.
Large shareholder
6,706 +0.0%
8.21
US$55,061 		6,706 +0.0% 8.21 US$55,061
2019-06-19 2019-06-18 PP Planned purchase
3.2
SVF Investments (UK) Ltd
Large shareholder
6,706 +0.0%
8.21
US$55,061 		6,706 +0.0% 8.21 US$55,061
2019-06-19 2019-06-18 PP Planned purchase
1.9
Roivant Sciences Ltd.
Large shareholder
6,706 +0.0%
8.21
US$55,061 		6,706 +0.0% 8.21 US$55,061
2019-06-19 2019-06-17 PP Planned purchase
QVT Associates GP LLC
Large shareholder
6,541 +0.0%
8.53
US$55,825 		6,541 +0.0% 8.53 US$55,825
2019-06-19 2019-06-17 PP Planned purchase
2.0
VIKING GLOBAL PERFORMANCE LLC
Large shareholder
6,541 +0.0%
8.53
US$55,825 		6,541 +0.0% 8.53 US$55,825
2019-06-19 2019-06-17 PP Planned purchase
1.5
Machado Patrick
Large shareholder
6,541 +0.0%
8.53
US$55,825 		6,541 +0.0% 8.53 US$55,825
2019-06-19 2019-06-17 PP Planned purchase
3.2
VIKING GLOBAL INVESTORS LP
Large shareholder
6,541 +0.0%
8.53
US$55,825 		6,541 +0.0% 8.53 US$55,825
2019-06-19 2019-06-17 PP Planned purchase
2.4
Lo Andrew
Large shareholder
6,541 +0.0%
8.53
US$55,825 		6,541 +0.0% 8.53 US$55,825
2019-06-19 2019-06-17 PP Planned purchase
Dexxon Holdings Ltd.
Large shareholder
6,541 +0.0%
8.53
US$55,825 		6,541 +0.0% 8.53 US$55,825
2019-06-19 2019-06-17 PP Planned purchase
3.2
SVF Investments (UK) Ltd
Large shareholder
6,541 +0.0%
8.53
US$55,825 		6,541 +0.0% 8.53 US$55,825
2019-06-19 2019-06-17 PP Planned purchase
1.9
Roivant Sciences Ltd.
Large shareholder
6,541 +0.0%
8.53
US$55,825 		6,541 +0.0% 8.53 US$55,825
2019-06-14 2019-06-14 PP Planned purchase
3.2
VIKING GLOBAL INVESTORS LP
Large shareholder
7,144 +0.0%
7.91
US$56,514 		7,144 +0.0% 7.91 US$56,514
2019-06-14 2019-06-14 PP Planned purchase
1.9
Roivant Sciences Ltd.
Large shareholder
7,144 +0.0%
7.91
US$56,514 		7,144 +0.0% 7.91 US$56,514
2019-06-14 2019-06-14 PP Planned purchase
Dexxon Holdings Ltd.
Large shareholder
7,144 +0.0%
7.91
US$56,514 		7,144 +0.0% 7.91 US$56,514
2019-06-14 2019-06-14 PP Planned purchase
3.2
SVF Investments (UK) Ltd
Large shareholder
7,144 +0.0%
7.91
US$56,514 		7,144 +0.0% 7.91 US$56,514
2019-06-14 2019-06-14 PP Planned purchase
2.4
Lo Andrew
Large shareholder
7,144 +0.0%
7.91
US$56,514 		7,144 +0.0% 7.91 US$56,514
2019-06-14 2019-06-14 PP Planned purchase
QVT Associates GP LLC
Large shareholder
7,144 +0.0%
7.91
US$56,514 		7,144 +0.0% 7.91 US$56,514
2019-06-14 2019-06-14 PP Planned purchase
2.0
VIKING GLOBAL PERFORMANCE LLC
Large shareholder
7,144 +0.0%
7.91
US$56,514 		7,144 +0.0% 7.91 US$56,514
2019-06-14 2019-06-14 PP Planned purchase
1.5
Machado Patrick
Large shareholder
7,144 +0.0%
7.91
US$56,514 		7,144 +0.0% 7.91 US$56,514
2019-06-14 2019-06-13 PP Planned purchase
3.2
VIKING GLOBAL INVESTORS LP
Large shareholder
7,367 +0.0%
7.95
US$58,543 		7,367 +0.0% 7.95 US$58,543
2019-06-14 2019-06-13 PP Planned purchase
1.9
Roivant Sciences Ltd.
Large shareholder
7,367 +0.0%
7.95
US$58,543 		7,367 +0.0% 7.95 US$58,543
2019-06-14 2019-06-13 PP Planned purchase
Dexxon Holdings Ltd.
Large shareholder
7,367 +0.0%
7.95
US$58,543 		7,367 +0.0% 7.95 US$58,543
2019-06-14 2019-06-13 PP Planned purchase
3.2
SVF Investments (UK) Ltd
Large shareholder
7,367 +0.0%
7.95
US$58,543 		7,367 +0.0% 7.95 US$58,543
2019-06-14 2019-06-13 PP Planned purchase
2.4
Lo Andrew
Large shareholder
7,367 +0.0%
7.95
US$58,543 		7,367 +0.0% 7.95 US$58,543
2019-06-14 2019-06-13 PP Planned purchase
QVT Associates GP LLC
Large shareholder
7,367 +0.0%
7.95
US$58,543 		7,367 +0.0% 7.95 US$58,543
2019-06-14 2019-06-13 PP Planned purchase
2.0
VIKING GLOBAL PERFORMANCE LLC
Large shareholder
7,367 +0.0%
7.95
US$58,543 		7,367 +0.0% 7.95 US$58,543
2019-06-14 2019-06-13 PP Planned purchase
1.5
Machado Patrick
Large shareholder
7,367 +0.0%
7.95
US$58,543 		7,367 +0.0% 7.95 US$58,543
2019-06-14 2019-06-12 PP Planned purchase
3.2
VIKING GLOBAL INVESTORS LP
Large shareholder
7,500 +0.0%
8.30
US$62,244 		7,500 +0.0% 8.30 US$62,244
2019-06-14 2019-06-12 PP Planned purchase
1.9
Roivant Sciences Ltd.
Large shareholder
7,500 +0.0%
8.30
US$62,244 		7,500 +0.0% 8.30 US$62,244
2019-06-14 2019-06-12 PP Planned purchase
Dexxon Holdings Ltd.
Large shareholder
7,500 +0.0%
8.30
US$62,244 		7,500 +0.0% 8.30 US$62,244
2019-06-14 2019-06-12 PP Planned purchase
3.2
SVF Investments (UK) Ltd
Large shareholder
7,500 +0.0%
8.30
US$62,244 		7,500 +0.0% 8.30 US$62,244
2019-06-14 2019-06-12 PP Planned purchase
2.4
Lo Andrew
Large shareholder
7,500 +0.0%
8.30
US$62,244 		7,500 +0.0% 8.30 US$62,244
2019-06-14 2019-06-12 PP Planned purchase
QVT Associates GP LLC
Large shareholder
7,500 +0.0%
8.30
US$62,244 		7,500 +0.0% 8.30 US$62,244
2019-06-14 2019-06-12 PP Planned purchase
2.0
VIKING GLOBAL PERFORMANCE LLC
Large shareholder
7,500 +0.0%
8.30
US$62,244 		7,500 +0.0% 8.30 US$62,244
2019-06-14 2019-06-12 PP Planned purchase
1.5
Machado Patrick
Large shareholder
7,500 +0.0%
8.30
US$62,244 		7,500 +0.0% 8.30 US$62,244
2019-06-11 2019-06-11 PP Planned purchase
2.0
VIKING GLOBAL PERFORMANCE LLC
Large shareholder
7,189 +0.0%
8.58
US$61,694 		7,189 +0.0% 8.58 US$61,694
2019-06-11 2019-06-11 PP Planned purchase
1.9
Roivant Sciences Ltd.
Large shareholder
7,189 +0.0%
8.58
US$61,694 		7,189 +0.0% 8.58 US$61,694
2019-06-11 2019-06-11 PP Planned purchase
QVT Associates GP LLC
Large shareholder
7,189 +0.0%
8.58
US$61,694 		7,189 +0.0% 8.58 US$61,694
2019-06-11 2019-06-11 PP Planned purchase
1.5
Machado Patrick
Large shareholder
7,189 +0.0%
8.58
US$61,694 		7,189 +0.0% 8.58 US$61,694
2019-06-11 2019-06-11 PP Planned purchase
3.2
VIKING GLOBAL INVESTORS LP
Large shareholder
7,189 +0.0%
8.58
US$61,694 		7,189 +0.0% 8.58 US$61,694
2019-06-11 2019-06-11 PP Planned purchase
3.2
SVF Investments (UK) Ltd
Large shareholder
7,189 +0.0%
8.58
US$61,694 		7,189 +0.0% 8.58 US$61,694
2019-06-11 2019-06-11 PP Planned purchase
2.4
Lo Andrew
Large shareholder
7,189 +0.0%
8.58
US$61,694 		7,189 +0.0% 8.58 US$61,694
2019-06-11 2019-06-11 PP Planned purchase
Dexxon Holdings Ltd.
Large shareholder
7,189 +0.0%
8.58
US$61,694 		7,189 +0.0% 8.58 US$61,694
2019-06-11 2019-06-10 PP Planned purchase
2.0
VIKING GLOBAL PERFORMANCE LLC
Large shareholder
7,500 +0.0%
8.35
US$62,594 		7,500 +0.0% 8.35 US$62,594
2019-06-11 2019-06-10 PP Planned purchase
1.9
Roivant Sciences Ltd.
Large shareholder
7,500 +0.0%
8.35
US$62,594 		7,500 +0.0% 8.35 US$62,594
2019-06-11 2019-06-10 PP Planned purchase
QVT Associates GP LLC
Large shareholder
7,500 +0.0%
8.35
US$62,594 		7,500 +0.0% 8.35 US$62,594
2019-06-11 2019-06-10 PP Planned purchase
1.5
Machado Patrick
Large shareholder
7,500 +0.0%
8.35
US$62,594 		7,500 +0.0% 8.35 US$62,594
2019-06-11 2019-06-10 PP Planned purchase
3.2
VIKING GLOBAL INVESTORS LP
Large shareholder
7,500 +0.0%
8.35
US$62,594 		7,500 +0.0% 8.35 US$62,594
2019-06-11 2019-06-10 PP Planned purchase
3.2
SVF Investments (UK) Ltd
Large shareholder
7,500 +0.0%
8.35
US$62,594 		7,500 +0.0% 8.35 US$62,594
2019-06-11 2019-06-10 PP Planned purchase
2.4
Lo Andrew
Large shareholder
7,500 +0.0%
8.35
US$62,594 		7,500 +0.0% 8.35 US$62,594
2019-06-11 2019-06-10 PP Planned purchase
Dexxon Holdings Ltd.
Large shareholder
7,500 +0.0%
8.35
US$62,594 		7,500 +0.0% 8.35 US$62,594
2019-06-11 2019-06-07 PP Planned purchase
2.0
VIKING GLOBAL PERFORMANCE LLC
Large shareholder
6,649 +0.0%
7.97
US$52,959 		6,649 +0.0% 7.97 US$52,959
2019-06-11 2019-06-07 PP Planned purchase
1.9
Roivant Sciences Ltd.
Large shareholder
6,649 +0.0%
7.97
US$52,959 		6,649 +0.0% 7.97 US$52,959
2019-06-11 2019-06-07 PP Planned purchase
QVT Associates GP LLC
Large shareholder
6,649 +0.0%
7.97
US$52,959 		6,649 +0.0% 7.97 US$52,959
2019-06-11 2019-06-07 PP Planned purchase
1.5
Machado Patrick
Large shareholder
6,649 +0.0%
7.97
US$52,959 		6,649 +0.0% 7.97 US$52,959
2019-06-11 2019-06-07 PP Planned purchase
3.2
VIKING GLOBAL INVESTORS LP
Large shareholder
6,649 +0.0%
7.97
US$52,959 		6,649 +0.0% 7.97 US$52,959
2019-06-11 2019-06-07 PP Planned purchase
3.2
SVF Investments (UK) Ltd
Large shareholder
6,649 +0.0%
7.97
US$52,959 		6,649 +0.0% 7.97 US$52,959
Explore more

More insider trading research around Urovant Sciences Ltd

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America